# MMRF CureCloud Research Initiative

> **NCT03657251** · — · TERMINATED · sponsor: **Multiple Myeloma Research Foundation** · enrollment: 1105 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **GENETIC:** liquid biopsy

## Key facts

- **NCT ID:** NCT03657251
- **Lead sponsor:** Multiple Myeloma Research Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-14
- **Primary completion:** 2023-12-29
- **Final completion:** 2023-12-31
- **Target enrollment:** 1105 (ACTUAL)
- **Why stopped:** The MMRF has learned of the limitations of using a blood sample to collect genomic data, compared to a bone marrow aspirate. We decided that our resources are best served in other areas at this time.
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03657251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03657251, "MMRF CureCloud Research Initiative". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03657251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
